A vipox virus-vectored Japanese encephalitis virus vaccines: use as vaccine candidates in combination with purified subunit immunogens
Open Access
- 31 December 1994
- Vol. 12 (7) , 633-638
- https://doi.org/10.1016/0264-410x(94)90269-0
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- A highly attenuated host range-restricted vaccinia virus strain, NYVAC, encoding the prM, E, and NS1 genes of Japanese encephalitis virus prevents JEV viremia in swineVirology, 1992
- Mice immunized with a subviral particle containing the japanese encephalitis virus prM/M and E proteins are protected from lethal JEV infectionVirology, 1992
- Immunisation with canarypox virus expressing rabies glycoproteinThe Lancet, 1992
- Overcoming inhibition of antibody responses to a malaria recombinant vaccinia virus caused by prior exposure to wild type virusVaccine, 1991
- Side-effects with Japanese encephalitis vaccineThe Lancet, 1991
- Efficacy studies on a canarypox-rabies recombinant virusVaccine, 1991
- Molecular Characterization of a Neutralizing Domain of the Japanese Encephalitis Virus Structural GlycoproteinJournal of General Virology, 1989
- Current Approaches to the Development of Dengue Vaccines and Related Aspects of the Molecular Biology of FlavivirusesThe Journal of Infectious Diseases, 1988
- Expression of Japanese encephalitis virus antigens in Escherichia coliVirology, 1987
- Neutralizing (54K) and Non-neutralizing (54K and 48K) Monoclonal Antibodies against Structural and Non-structural Yellow Fever Virus Proteins Confer Immunity in MiceJournal of General Virology, 1986